India has given emergency approval to both the Oxford / AstraZeneca Corona virus vaccine and the locally developed covacan, launching a vaccination campaign in the world’s largest covid-19 vaccine.
At a press conference on Sunday, the Comptroller General of Drugs for India said the decision to approve both the Oxford Vaccine and the Vaccine, which is manufactured by the Indian company Bharat Biotech and funded by the government, was a “careful examination”. Checked. Of data.
The UK became the second country to approve the emergency use of the Oxford / AstraZeneca vaccine, known in India as CowShield, after it was given the green light on Wednesday.
Approval comes at a crucial time. India, a country with a population of over 1.3 billion, has more than 10.3 million cases of cod 19, the second highest in the world and 149,000 deaths. On Sunday, Prime Minister Narendra Modi called the approval a “turning point”.
India plans to vaccinate 300 million people in the first phase of its immunization campaign, giving priority to 30 million frontline healthcare workers, members of the police and the armed forces. The vaccine will then be given to people over the age of 50 and people with chronic diseases. The vaccine will be given free of charge.
However, the approval of the vaccine has been met with some concern as the vaccine is still undergoing Phase 3 clinical trials and the full results of the vaccine’s efficacy have not been published.
The All India Drug Action Network, a public health group, said it was “surprised” by the decision to approve a vaccine in trials so far. The government had earlier promised that Kovacson, developed in collaboration with a government-run body, the Indian Medical Research Council, would be ready for distribution by August 2020.
Senior opposition leader Shashi Tharoor tweeted his concerns about Kovacson. “Phase 3 trials have not yet taken place on Kovacson. Approval was premature and can be dangerous.
India’s Comptroller General of Drugs, VG Somani, tried to allay any fears. “If there is the slightest concern for safety, we will never accept anything,” he said on Sunday. Vaccines are 110% safe.
Importantly, both CoveShield and Covacin will be manufactured in India, a country that is already the world’s largest pharmaceutical company and produces about 60% of the world’s vaccines.
The Oxford / AstraZeneca vaccine will be developed by the Serum Institute of India, which has already stockpiled 40 million doses before approval. The company has promised to produce 300 million doses by July, and has repeatedly assured that 50% of its vaccines will be allocated to India.
Adar Poonawala, CEO of the Serum Institute, said on Sunday that he would not allow the vaccine to be exported for several months, meaning that poor countries would have to wait before starting their vaccination programs. May fall While most of the vaccines made this year are safe with rich countries, the Serum Institute, the world’s largest vaccine maker, is likely to impose more taxes on developing countries.
However, India faces major challenges in vaccine distribution across a wide country. Health care is uneven, resources and energy are scarce, and access to rural areas is often difficult. The government has almost decided to administer this vaccine. Has begun training 20,000 health workers and last week trials were conducted in four states using placebo vaccines administered by trained professionals.
CowShield and Covacin need to be stored at a temperature of only 2-8C, far more manageable than Pfizer and modern vaccines run in Europe and the United States.
However, there are concerns that India’s cold chain-refrigerated resources enable vaccines to be safely transported and stored. The government has brought in the Ministries of Aviation and Transport to work out a plan for how the vaccine can be delivered across the country.
The government said it wanted to draw attention to the highly successful polio eradication program and the immunization program, which vaccinates about 27 million children annually.
STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ